Cargando…

Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients

BACKGROUND: The aim of this study was to determine the frequency and characteristics of bone and joint complications, specifically bone fragility, joint replacement surgery, and arthropathy, in hereditary hemochromatosis (HH) and related factors. METHODS: This study was a cross-sectional observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Chi-Duc, Morel, Vincent, Pierache, Adeline, Lion, Georges, Cortet, Bernard, Flipo, René-Marc, Canva-Delcambre, Valérie, Paccou, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366396/
https://www.ncbi.nlm.nih.gov/pubmed/32728396
http://dx.doi.org/10.1177/1759720X20939405
_version_ 1783560211544408064
author Nguyen, Chi-Duc
Morel, Vincent
Pierache, Adeline
Lion, Georges
Cortet, Bernard
Flipo, René-Marc
Canva-Delcambre, Valérie
Paccou, Julien
author_facet Nguyen, Chi-Duc
Morel, Vincent
Pierache, Adeline
Lion, Georges
Cortet, Bernard
Flipo, René-Marc
Canva-Delcambre, Valérie
Paccou, Julien
author_sort Nguyen, Chi-Duc
collection PubMed
description BACKGROUND: The aim of this study was to determine the frequency and characteristics of bone and joint complications, specifically bone fragility, joint replacement surgery, and arthropathy, in hereditary hemochromatosis (HH) and related factors. METHODS: This study was a cross-sectional observational study of 93 patients with HH. Radiographs of the hands, wrists, knees, and ankles were scored for joint space narrowing, erosions and cysts, osteophytes, and chondrocalcinosis. Prevalent (vertebral and non-vertebral) fragility fractures were recorded and bone mineral density (BMD) was systematically evaluated by dual energy X-ray absorptiometry. Bone fragility was defined as (i) a T-score ⩽ −2.5 at any site with or without a prevalent fragility fracture, or (ii) a T-score between −1.0 and −2.5 at any site and a prevalent fragility fracture. RESULTS: The mean age of the patients was 60.0 (11.2) years, and 58.0% of them were men. The frequency of radiographic MCP2–3 arthropathy was 37.6% (95% CI 0.28–0.48). Radiographic MCP2–3 arthropathy was independently associated with older age [OR 1.17 (1.09–1.26) per year, p < 0.0001], male sex [OR 3.89 (1.17–12.97), p = 0.027] and C282Y+/+ genotype [OR 4.78 (1.46–15.68), p = 0.010]. The frequency of joint replacement surgery was 12.9% (95% CI 0.07–0.21). The frequency of bone fragility was 20.4% (95% CI 0.13–0.30). Bone fragility was independently associated with hepatic cirrhosis [OR 8.20 (1.74–38.68), p = 0.008]. DISCUSSION: Radiographic MCP2–3 arthropathy was found to occur in 37.6% of patients with HH. The association observed between this form of arthropathy and C282Y homozygosity, male sex, and older age suggests that demographic characteristics and genetic background are likely to be major determinants of this joint disorder and play a more important role than severity of iron overload. Bone fragility was observed in a fifth of the patients with HH, independently of genetic background and severity of iron overload, and was strongly associated with hepatic cirrhosis. CONCLUSION: Future investigations should focus on pathogenesis and early identification of patients at risk of developing bone and joint complications secondary to HH.
format Online
Article
Text
id pubmed-7366396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-73663962020-07-28 Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients Nguyen, Chi-Duc Morel, Vincent Pierache, Adeline Lion, Georges Cortet, Bernard Flipo, René-Marc Canva-Delcambre, Valérie Paccou, Julien Ther Adv Musculoskelet Dis Original Research BACKGROUND: The aim of this study was to determine the frequency and characteristics of bone and joint complications, specifically bone fragility, joint replacement surgery, and arthropathy, in hereditary hemochromatosis (HH) and related factors. METHODS: This study was a cross-sectional observational study of 93 patients with HH. Radiographs of the hands, wrists, knees, and ankles were scored for joint space narrowing, erosions and cysts, osteophytes, and chondrocalcinosis. Prevalent (vertebral and non-vertebral) fragility fractures were recorded and bone mineral density (BMD) was systematically evaluated by dual energy X-ray absorptiometry. Bone fragility was defined as (i) a T-score ⩽ −2.5 at any site with or without a prevalent fragility fracture, or (ii) a T-score between −1.0 and −2.5 at any site and a prevalent fragility fracture. RESULTS: The mean age of the patients was 60.0 (11.2) years, and 58.0% of them were men. The frequency of radiographic MCP2–3 arthropathy was 37.6% (95% CI 0.28–0.48). Radiographic MCP2–3 arthropathy was independently associated with older age [OR 1.17 (1.09–1.26) per year, p < 0.0001], male sex [OR 3.89 (1.17–12.97), p = 0.027] and C282Y+/+ genotype [OR 4.78 (1.46–15.68), p = 0.010]. The frequency of joint replacement surgery was 12.9% (95% CI 0.07–0.21). The frequency of bone fragility was 20.4% (95% CI 0.13–0.30). Bone fragility was independently associated with hepatic cirrhosis [OR 8.20 (1.74–38.68), p = 0.008]. DISCUSSION: Radiographic MCP2–3 arthropathy was found to occur in 37.6% of patients with HH. The association observed between this form of arthropathy and C282Y homozygosity, male sex, and older age suggests that demographic characteristics and genetic background are likely to be major determinants of this joint disorder and play a more important role than severity of iron overload. Bone fragility was observed in a fifth of the patients with HH, independently of genetic background and severity of iron overload, and was strongly associated with hepatic cirrhosis. CONCLUSION: Future investigations should focus on pathogenesis and early identification of patients at risk of developing bone and joint complications secondary to HH. SAGE Publications 2020-07-16 /pmc/articles/PMC7366396/ /pubmed/32728396 http://dx.doi.org/10.1177/1759720X20939405 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Nguyen, Chi-Duc
Morel, Vincent
Pierache, Adeline
Lion, Georges
Cortet, Bernard
Flipo, René-Marc
Canva-Delcambre, Valérie
Paccou, Julien
Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients
title Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients
title_full Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients
title_fullStr Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients
title_full_unstemmed Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients
title_short Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients
title_sort bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366396/
https://www.ncbi.nlm.nih.gov/pubmed/32728396
http://dx.doi.org/10.1177/1759720X20939405
work_keys_str_mv AT nguyenchiduc boneandjointcomplicationsinpatientswithhereditaryhemochromatosisacrosssectionalstudyof93patients
AT morelvincent boneandjointcomplicationsinpatientswithhereditaryhemochromatosisacrosssectionalstudyof93patients
AT pieracheadeline boneandjointcomplicationsinpatientswithhereditaryhemochromatosisacrosssectionalstudyof93patients
AT liongeorges boneandjointcomplicationsinpatientswithhereditaryhemochromatosisacrosssectionalstudyof93patients
AT cortetbernard boneandjointcomplicationsinpatientswithhereditaryhemochromatosisacrosssectionalstudyof93patients
AT fliporenemarc boneandjointcomplicationsinpatientswithhereditaryhemochromatosisacrosssectionalstudyof93patients
AT canvadelcambrevalerie boneandjointcomplicationsinpatientswithhereditaryhemochromatosisacrosssectionalstudyof93patients
AT paccoujulien boneandjointcomplicationsinpatientswithhereditaryhemochromatosisacrosssectionalstudyof93patients